Corcept Therapeutics
CORT | NASDAQ
$80.69
-$0.43 (-0.53%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 761.41M | 675.04M | 482.38M | 401.86M | 365.98M | 353.87M |
Cost of Revenue | 12.98M | 10.88M | 6.48M | 5.39M | 5.28M | 5.58M |
Gross Profit | 748.43M | 664.16M | 475.89M | 396.47M | 360.7M | 348.29M |
Operating Income | 44.8M | 136.95M | 107.28M | 112.63M | 124.48M | 128.2M |
Interest Income | 21.67M | 24.54M | 17.28M | 3.56M | 529K | 3.4M |
Pretax Income | 66.46M | 161.49M | 124.56M | 116.19M | 125.01M | 131.6M |
Net Income | 99.65M | 139.73M | 106.14M | 101.42M | 112.51M | 106.01M |
Selling & General & Admin | 448.73M | 280.32M | 184.26M | 152.85M | 122.36M | 105.33M |
Research & Development | 254.91M | 246.89M | 184.35M | 130.99M | 113.86M | 114.76M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 703.63M | 527.21M | 368.61M | 283.84M | 236.22M | 220.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 716.61M | 538.09M | 375.09M | 289.22M | 241.5M | 225.67M |
Income Tax Expense | -33.19M | 20.28M | 18.42M | 14.77M | 12.49M | 25.59M |
Shares Outstanding (Basic) | 103.86M | 103.23M | 103.56M | 106.79M | 115.65M | 115.41M |
Shares Outstanding (Diluted) | 119.99M | 113.48M | 111.74M | 115.97M | 125.96M | 124.19M |
EPS (Basic) | 0.95 | 1.35 | 1.02 | 0.95 | 0.97 | 0.92 |
EPS (Diluted) | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 | 0.85 |
EBITDA | 68.35M | 162.83M | 125.6M | 117.45M | 127.95M | 130.44M |
EBIT | 66.46M | 161.49M | 124.56M | 116.19M | 125.01M | 128.2M |
Depreciation & Amortization | 1.89M | 1.34M | 1.04M | 1.26M | 3.07M | 2.24M |
Add to Watchlist
Select watchlists to add or remove CORT